{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60001098",
    "licUnit": "1",
    "validDate": "2029-03-11 00:00:00.000",
    "issueDate": "2019-03-11 00:00:00.000",
    "oriIssueDate": "2019-03-11",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000109801",
    "prodNameC": "安捷達注射液",
    "prodNameE": "AMGEVITA Solution for Injection",
    "indicationsName": [
        "1. 類風濕性關節炎：AMGEVITA適用於患有中度至重度類風濕性關節炎，並且曾經對一種或超過一種的DMARDs藥物有不適當反應的成人病人，可減輕症狀與徵兆（包括主要臨床反應和臨床緩解）、抑制結構上損害的惡化。AMGEVITA可單獨使用也可以和MTX或其他DMARDs藥物併用。\r\n2. 乾癬性關節炎：適用於對疾病緩解型抗風濕藥物無療效之成人活動性與進行性乾癬性關節炎。AMGEVITA可單獨使用也可以和MTX或其他DMARDs藥物併用。\r\n3. 僵直性脊椎炎：適用於減輕患有活動性僵直性脊椎炎的病人之症狀與徵兆。\r\n4. 克隆氏症：適用於對傳統治療無效之成人中度至重度克隆氏症，可減輕症狀與徵兆及誘導與維持臨床緩解。AMGEVITA亦適用於對infliximab已經失去療效或無耐受性之成人中度至重度克隆氏症，可減輕症狀與徵兆及誘導與維持臨床緩解。\r\n5. 乾癬：對其他全身性治療，包括cyclosporine、MTX 或其他光化學療法無效、有禁忌或無法耐受之中度至重度乾癬成人病人。\r\n6. 潰瘍性結腸炎：AMGEVITA適用於對於皮質類固醇和\/或6-mercaptopurine (6-MP) 或azathioprine (AZA) 等傳統治療無效、或對這種療法不耐受或有醫療禁忌之中度至嚴重活動性潰瘍性結腸炎成人病人。\r\n7. 腸道貝西氏症：AMGEVITA適用於治療對傳統治療無效之腸道貝西氏症 (Intestinal Behcet’s Disease) 病人。\r\n8. 化膿性汗腺炎：AMGEVITA適用於對傳統全身性療法反應不佳的進行性中到重度化膿性汗腺炎（又可稱作acne inversa）之成人病人。\r\n9. 葡萄膜炎：AMGEVITA適用於治療對類固醇反應不佳，或不適合使用類固醇之成年病人的非感染性中段、後段和全葡萄膜炎。\r\n10. 小兒適應症：\r\n(1) 幼年型自發性多關節炎：AMGEVITA與Methotrexate併用適用於2歲及以上患有活動性幼年型自發性多關節炎，並且曾經對一種或超過一種DMARDs藥物反應不佳之病人。AMGEVITA可單獨用於對Methotrexate無法耐受或不適合持續使用之病人。\r\n(2) 小兒克隆氏症：AMGEVITA適用於對皮質類固醇及免疫調節劑 (Immunomodulators) 反應不佳之6歲或大於6歲中度至重度克隆氏症病人，可減輕症狀與徵兆及誘導與維持臨床緩解。\r\n(3) 小兒葡萄膜炎：AMGEVITA適用於治療2歲以上患有慢性非感染性前葡萄膜炎，並且對傳統治療反應不佳之小兒病人。"
    ],
    "does": "227D",
    "packageUnit": [
        {
            "packageSpec": "0.8 mL預充填",
            "packageUnit": "7B"
        },
        {
            "packageSpec": "0.4 mL預充填",
            "packageUnit": "7B"
        },
        {
            "packageSpec": "0.8 mL預充填",
            "packageUnit": "D6"
        },
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "D",
    "mainCategory": "D",
    "drBaseId": "D8A38380-4B07-429E-BB4F-AC42970ADC55",
    "subCategory": [],
    "ingredientsDesc": [
        "ADALIMUMAB",
        "ADALIMUMAB"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "1D 須執行風險管理計畫",
        "67 成品已完成元素不純物評估(Option 1、2a、2b)",
        "91 生物相似性藥品"
    ],
    "applicantName": "台灣安進藥品有限公司 ",
    "applicantAddr": "臺北市信義區松仁路100號13樓之1、之2",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2024-03-11",
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "423532DD-1FD3-41CA-B946-CD6BC85A1FFE",
            "factoryCode": "1",
            "factoryName": "AMGEN MANUFACTURING LIMITED LLC",
            "factoryAddr": "STATE ROAD 31, KM 24.6 JUNCOS, PUERTO RICO 00777-4060",
            "factoryCompanyAddr": "",
            "countryCode": "PR",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FPR0062100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "B12D8941-2020-46C1-AD7C-4CCD94217EC2",
            "factoryCode": "2",
            "factoryName": "AMGEN INC.",
            "factoryAddr": "ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 U.S.A.",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FUS0325000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "589C2F22-0C91-4951-A00A-B3C402001647",
            "factoryCode": "2",
            "factoryName": "IMMUNEX RHODE ISLAND CORPORATION",
            "factoryAddr": "40 TECHNOLOGY WAY, WEST GREENWICH RHODE ISLAND 02817, USA",
            "factoryCompanyAddr": "",
            "countryCode": "US",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FUS0866000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "9200094700",
            "ingredientsName": "ADALIMUMAB",
            "ingredientsDesc": "ADALIMUMAB",
            "concentDesc": "",
            "concent": "20.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        },
        {
            "ingredientsKind": "1",
            "ingredientsCode": "9200094700",
            "ingredientsName": "ADALIMUMAB",
            "ingredientsDesc": "ADALIMUMAB",
            "concentDesc": "",
            "concent": "40.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "2",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L04AB04"
        }
    ],
    "udiInfoList": [],
    "licBaseId": "986C1BF0-F0F5-42BE-98D4-3A5CA2976C99"
}